Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 28143
IPSCIO Record ID: 1010
Licensor has certain rights to a humanized antibody directed against the CD33 antigen and designated by Licensor as HuM195.
HuM195 Antibody means the humanized version of the m195 antibody directed against the CD33 antigen.
Patent No. 5,585,089, Humanized Immunoglobulins
Patent No. 5,693,761, Polynucleotides Encoding Improved Humanized Immunoglobulins
Patent No. 5,693,762, Humanized Immunoglobulins
Patent No. 6,180, 370 Humanized Immunoglobulins and Method of Making the Same
The Licensee secured exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes.
Alpha particles are of considerable interest for radioimmunotherapy applications since their short range in soft tissue is limited to only a few cell diameters. The delivery of such high energy in such a small volume, or high-linear-energy-transfer (LET), makes alpha particles especially well suited for targeting micrometastatic disease and single tumor cells such as leukemia and other blood-borne disease.
IPSCIO Record ID: 1351
Licensee shall have the right to grant sublicenses under the license to employ Affiliates and Third Parties.
SK979 – Targeted alpha particle therapy with DOTA-based complexes of Ac225 – US Provisional application number 60/232,909.
SK933 – Liposome encapsulation of Ac225 – US Provisional application number 60/212,186.
SK352 – Alpha emitting constructs and used thereof – US Provisional application number 60/086,772.
SK712 – Bi-213 Generator and used thereof – US Provisional application number 60/079,902.
The field shall mean all therapeutic use of Licensed Products in humans and animals.